However, activation of cell signalling via the VEGFR/VEGF-A or PDGFR-β/PDGF-BB system as well as concomitant PTK787-treatement was shown to be insufficient in effectively reduce migration of leiomyosarcoma cell lines. This evidence concerns the gene PDGFRB and leiomyosarcoma.